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ABSTRACT: A comprehensive cost model of wildlife rabies is presented. A total of 11 factors were viewed to comprise the
diverse agricultural, insurance, medical, and veterinary expenses associated with rabies (i.e., pet vaccinations, livestock
vaccinations, pet replacements, livestock replacements, pre-exposure prophylaxis for humans, post-exposure prophylaxis for
humans, adverse medical reactions, animal conml activities, public health charges, quarantine costs, and human death settlements).
These factor costs form the basis of potential savings to be gained fiom rabies control activities. Irrespective of incidence, per unit
costs and ranges were found to be greatest for livestock replacement, post-exposure prophylaxis, adverse medical reactions, and
human death settlements, with substantial costs of adverse medical reactions and human deaths ocnvring infrequently but due to
potential insurance or litigation claims. Empirical studies are needed to document the incidence of these factors during preepizootic,epizootic,and post-epizootic phases of wildlife rabies.
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identify key sources of potential savings that could result
INTRODUCTION
The median number of annual human deaths fkom h m wildlife rabies control activities, especially oral
rabies in the U. S. is low- less than 3 per year (Childs rabies vaccination (ORV) programs.
2002, Krebs et al. 2003). Still, this disease poses a major
economic and public health concern due to diverse costs COSTS-SAVINGS MODEL OF RABIES
incurred h m human or domestic animal contacts with Theoretical Description
In recent reviews, Meltzer and Rupprecht (1998% b)
suspected rabid animals (Meltzer and Rupprecht
stated that rabies impacts the global economy as mainly
1998a,b).
Recent data (Childs 2002) show that rabies cases human and domestic animal health costs- prevention and
involving dogs (Canis familiaris) and cats (Felis catus) treatment. We extend this view and identify diverse
account for only 5 - 10% (QOOIyear) of all animal rabies agricultural, insurance, medical, and veterinary costs that
cases. Conversely, the incidence of rabies in wildlife has can be attributed to outbreaks of the disease. The
increased dramatically in the past 25 years, with 7,967 potential saving of all or a portion of these wsts is the
positive cases reported in 2002 (Krebs et al. 2003). benefit of rabies control.
Meltzer (1996) published a cost-savings model of
Multiple variants of the rabies vllus occur in this country:
bat (e.g., Eptesim CUP, Lasionyctem noctivagans), raccoon-variant rabies that viewed expenditures and
coyote (Canis latrans), fox (e.g., Vulpes vulpes, Alopex savings ffom ORV to vary with stages of an epizootic
lagopus), raccoon (Procyon lotor), and skunk (e.g., (i.e., pre-, during-, and post-epizootic). He discussed pet
Mephitis mephitis, Spilogale putoris) (Childs 2002). vaccinations and post-exposure medical treatments as the
Mammals infected with these variants occupy prescribed two main factors determining the economic impacts of
geographical regions, with bat-variant rabies overlapping raccoon-variant rabies epizootics. During an epizootic,
many regions (Childs 2002). Interestingly, during the disease costs are driven by increased rates of animal
1990s bats accounted for three-fourths of the 32 human vaccination and human treatment. As pet owners become
focused on the protection of their animals from rabies, pet
cases of rabies (Niezgoda et al. 2002).
Uncertainty characterizes the economic costs of rabies vaccinations increase; a d as individuals learn of a rabies
throughout the U.S. While several studies have attempted epizootic, they want more liberal dispensing of medical
to quantify individual medical (see Kreindel et al. 1998, treatments for practically any suspicious animal bite or
Shwiff et al. In Manuscript, Uaaa et al. 1992) and secondary contact with another exposed victim.
Meltzer (1996) attributed potential savings from a
veterinary (Meltzer 1996) costs, estimates of other
potential costs associated with the disease remain raccoon-variant ORV Program to the difference between
unknown. Here, we describe a comprehensive model of pre-epidemic (baseline) versus epidemic and postthe costs attributed to rabies. Minimum-maximum epidemic costs for these vaccinations and medical
estimates of the individual event costs (i.e., per unit cost) treatments. We agree with Meltzer's (1996) model, but
related to 11 factors were derived using Internet sites, we contend that numerous cost variables behave similar
, personal to these two costs. Because few empirical data are
published reports, statistical data s e ~ c e s and
inquiries.
This information helps to reduce the available for these variables, the significance of these
uncertainty of economic costs linked with rabies and to costs in wildlife rabies epizootics is largely unknown.

Cost Equation
The following equation describes our view of the
wsts and potential savings associated with wildlife
rahies:

where CR is the additive cost ($US) of a multi-year
epizootic of some wildlife-variant of rabies. This cost is
attributed to 11 main independent variables: PV - pet
vaccinations (n x $US/vaccination), LV - livestock
vaccinations (n x $US/vaccination), PR - pet animal
replacements (n x $US/animal for rabies-caused deaths),
LR - livestock replacements (n x $USihead by species),
PreEP - human pre-exposure-prophylaxis
(n x $US/
- ..
vaccination), PEP 1hu& post-exposure-pr~phylawis
(n
x $US/treatments), AR - Adverse reaction charges (n x
$US/event), PH - public health charges (n x $US/event
for case investigations and laboratory tests), AC - animal
control costs (n x $US/event ), Q - quarantine of suspected rabid animals (n x $US/event), HD - insured
human death claims (n x $US/death).

RELATIVE PER-UNIT COST ESTLMATES
We gleaned low and high cost data for each factor in
our model from Intemet sites, published reports, statistical
data services, or personal inquiries. Descriptive paragraphs were used to explain the nature of these empirical
values and a graph was prepared to show the relative
minjmum-maximum difference in these factor wsts (see
Figures l a and lb). We converted reported cost values to
present values based on the intervening annual reported
Consumer Price Indices (International Monetary Fund
2003).
Pet Vaccination (PV)
Prices for rabies vaccine and animal examination
varied h m a low of $5.00 and $0.00 at cost-of-vaccineonly or "free" clinics (Humphrey 1971, Uaaa et al. 1992)
to a high of $15.00 and $43.00, respectively (i.e., personal
phone call by RTS to a veterinarian in New York, with
the examination fee for a booster shot usually waived). A
well-derived mean estimate of PV is $19.36 in 2003 US$
(see Meltzer 1996). During epizootics, many municipalities underwrite some PV costs and hold clinics that
typically charge $5.00 for the vaccine, with local
veterinarians volunteering their time to administer the
injections. The recommended regimen for rabies PV is
annually or triennially based upon the chosen vaccine, the
prior immunization history, and local regulations
(National Association of State Public Health Veterinarians Committee 2004). Many pet owners opt for annual
PV, especially if a rabies epizootic occurs in their area.
Livestock Vaccination (LV)
Rabies vaccines for cattle, equines, and sheep are
available; no vaccines for swine or goats are cwently
approved (Briggs et al. 2002, National Association of
State Public Health Veterinarians Committee 2004).
Preventative vaccinations must be given to livestock
annually; therapeutic vaccinations after onset of symp-
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Figure 1 . (A) Bar graph of low and high factor wsts
obtained for the 11 factors in the rabiescost model;
(B) bar graph of low and high factor costs with AR and HD
removed (9 factors).

toms (e.g., unusual behavior, unexplained choking, partial
paralysis) are rarely effective due mainly to the slow
onset of pathogenic signs and the progression of the
disease before treatment (Humphrey 1971, Childs 2002).
Few states maintain records of preventative or therapeutic
rabies LV, with Texas a noteworthy exception (Wilson
and Clark 2001).
Charges for rabies LV also varied widely. Low and
high charges ranged from $10.00 for the vaccine (rancher
administering shot) to $50.00 for the vaccine and
examination by a veterinarian and a $1.00 per mile "call
charge", respectively. Assuming a 20-mile trip for the
veterinarian, this higher cost would be $70.00. While
authorization to purchase and to administer the vaccine is
limited to veterinarians in many states, enforcement is
poor; ranchers in some states can buy the vaccine directly
from a veterinary supply store and administer the shots.

Pet Replacement (PR)
The cost of replacing a pet depends upon pedigree and
lineage of the animal. We arbitrarily set the minimum
and maximum PR costs for a non-pedigreed and

pedigreed dog at $25.00 (i.e., local pound animal) and
$1,000.00 (i.e., exclusive breeder and pedigreed animal
with lineage documents), respectively. Replacement of a
cat, ferret, or rodent would be priced within these values.

variance reported).

Post-Exposure Prophylaxis (PEP)
A typical human PEP regimen is somewhat similar to
Pre-EP; however, the wound is intiltrated with 20 1.U.kg
Livestock Replacement (LR)
Human Rabies Immune Globulin (HRIG) at the time of
The costs of LR can be derived from current market initial treatment and the rabies vaccine regimen entails 5
data. Granted, rancherslfannm could contend that this repeated IM injections of HDCV, PCEC, or RVA on days
underestimates the investment in each animal due to life- 0.. 3.7.
, , 14. and 28 lCDC 1999).
long veterinary charges or long-term genetic breeding
A nurdber of s h i e s have provided empirical costs for
investments in an animal. Still, these market price PEP; high variance has characterized these estimates
valuations afford useful minimum and maximum cost (Kreindel, et al. 1998, Shwiff et al. In Manuscript, Uhaa
estimates for livestock. [Note - The reader may verify et al. 1992). Kreindel et al. (1998) reported a median PEP
suggested prices by checking available internet sites using cost of $2,688 ($2,376) that varied fiom a low of $1,174
diverse search engines; here, we provide representative to a high of $5,031 (i.e., $1,038 to $4,447 reported for
example sites.] Replacement of a representative steer1 1996). Shwiff et al. (In Manuscript) reported a mean
heifer at current market value would cost $825 (i.e., 1,000 $2,254 PEP, minimum and maximum costs of $257 and
Ib. @ $82.50/cwt; h~://usda.mdib.comell.eddre~orts $5,673, respectively (i.e., this low value was reported by
lnassr/pricdpap-bb/2004/amr 0304.txt), replacement of a one clinic and may have represented a partial PEP). Uhaa
representative calf would cost $1 11 ( e , 100 lb. @ et al. (1992) reported a mean PEP cost of $1,586 ($1,138
$1 11.00Icwt;
usda.marinlib.comell.eddre~orts/msr in 1990; no variance reported). Thus, using these
&ice /pa~-bb/soo4/amr0304.txt), and replacement of a empirical data, the minimum and maximum direct cost
representative dairy cow would average $1,130
for a human PEP treatment today is $257 and $5,673,
usda.mannlib.comell.eddre~orts/nassr/pricdpap-bb/2004respectively, but typical direct PEP costs would be
/ a m 0304.txt). Replacement of a sheep and lamb would between $1,586 and $2,688.
cost approximately $62 (i.e., 150 lb. @ $41.20/cwt;
usda.mdib.comell.eddre~orts/~ssr/~ricdpap-bb/2004
Adverse Reactions (AR)
laear 0304.txt) and $65 (i.e., 60 ib. @ $107.00/cwt;
Adverse medical effects are linked with both PreEp
usda.mannlib.comell.eddre~ortd~ssr/~ricdpap-bb/2004
and PEP (CDC 1999). Prior studies have shown that 30 Iamr 0304.txt), respectively. Horse prices varied with 74% of HDCV recipients note local pain, redness,
lineage and breed; we estimated this replacement cost at swelling, and itching at injection sites, 5 - 40% of HDCV
between $1,000.00 (i.e., riding horse) and $30,000.00 recipients develop systemic reactions (e.g., headache,
nausea, abdominal pain, dizziness), and 3 cases
(i.e., dressage or event mount; htt~://www.hhho~~e,com
/showihorses.ph~rderb~=~,rice).
developed neurologic effects resembling Guillain-Bad
syndrome which alleviated in 512 weeb (CDC 1999).
Pre-Exposure Prophylaxis (Pre-EP)
Infiltration of a wound with HRIG has also been linked
Preventative rabies prophylaxis is typically provided with localized pain and fever (CDC 1999).
to some animal control, veterinary, and animal research
Studies to estimate the actual costs of these AR effects
professionals (Briggs et al. 2002, CDC 1999, Uaaa et al. are non-existent. Individuals experiencing localized and
1992). The treatment regimen involves three 1.0-ml in- mild systemic effects would probably rely on inexpensive
tramuscular (IM) doses of Human Diploid Cell Vaccine "over-the-counter" analgesics or possibly make one or
(HDCV), Purified Chick Embryo Cell Vaccine (PCEC), two additional visits to a primaq care physician. We
or Rabies Vaccine Adsorbed P A ) on days 0, 7, and arbitrarily estimated these costs as between $5.00 (e.g.,
either 21 or 28; serologic monitoring then determines the aspirin, skin ointment) and $150.00 (e.g., 2 physician
use of booster shots usually once every 0.5 to 2 years visits with no health insurance), respectively. Obviously,
depending upon risk of exposure (CDC 1999, Munay and the few patients that experience neurologic side effects
Arguin 2000).
might seek some kind of insurance or malpractice
Kreindel et al. (1998) estimated the median HDCV remuneration; this could be sizable, depending upon the
dose cost at $328 (i.e., $221 in 1998 dollars) with a severity of the syndrome. We arbitrarily estimated these
minimum-maximum of $119 - $716 (i.e., $80 - $483 in claims at between $00 and $250,000.
Additionally, Shwiff et al. (In Manuscript) estimated
1998 dollars). Based on these data and the prescribed 3dose series for PreEP, we estimated that the current low the indirect patient costs of a rabies exposure at $680 (no
and high charges for PreEP would be $357 and $2,148, variance reported), with alternative medicines, lost wages,
respectively (i.e., excluding possible physician charges). travel, and other (e.g., day care, therapy) costs of $57,
Murray and Arguin (2000) reported a mean Pre-EP 3- $140, $12, and $471, respectively (no variances reported).
dose intramuscular (IM) cost as $563 or $188/dose (i.e., Some AR costs were probably contained in these indirect
$468 and $156/dose in 2000), with an additional $83 (i.e., estimates.
$71 in 2000) for serologic verification of immunizationa mean total cost of $646. Interestingly, Uaaa et al. Public Health (PEQ
To our knowledge, only Shwiff et al. (In Manuscript)
(1992) estimated the mean cost of Pre-EP at $2,683
($1,860 reported for 1988 pre-epizootic phase with have attempted to estimate a per unit case cost for public
physician costs included) per treatment series (i.e., no health intavention to deal with rabies. They reported a

mean $121 wst (no variance reported) for personnel and
related investigatory activities.

Animal Control (AC)
Shwiff et al. (In Manuscript) also reported an AC
estimate, but this did not separate AC and Q charges. The
mean wmbined AC and Q cost was reported as $290 (no
variance reported).

Quarantine (Q)
Current national recommendations for a dog, cat, or
fexret that bites a human require a 10-day isolation and
observation period (National Association of State Public
Health Veterinarians Committee 2004). For animals
potentially exposed to a suspected or confirmed rabid
animal, recommendations involve a 45-day isolation and
observation period assuming that the biting animal is
currently vaccinated; this isolation and observation period
is extended to 6 months if the animal is not currently
vaccinated for rabies (National Association of State
Public Health Veterinarians Committee 2004).
Of course, the capture of pets is common following a
suspected exposure, whereas the capture of wildlife is
rare. Despite the cited recommendations and circumstances, most municipal or county governments impose
the 10-day period in all cases- a questionable policy
considering the long incubation period of rabies virus213 days (Niezgoda et al. 2002). Most of these municipal
and county governments use their own pound or local
Humane Society facilities for holding animals; fees are
billed to the pet owner or, in the case of captured wildlife,
i n c d by the municipality. Representative charges
consist of a $40.00 impound fee and an $18.00/day
maintenance fee ($220.00 total) for dogs and cats (pen.
wmrnun., Scott Temple, Larimer County, CO Humane
Society, 2003). Pets that were vaccinated for rabies and
bite a person are usually wnfined (quarantined) at the
owner's property for observation (no c o s t t the risk of
losing track of the pet is low. Livestock involved in
suspected rabid wildlife exposures are usually corralled
and observed at the stockman's ranch or farm (no cost).

Human Death (HD)
Obviously, it is difficult to place a monetary valuation
on a human life; nevertheless, these deaths must be
counted as rabies-incurred impacts. To quantify low and
high impacts from these deaths, we arbitrarily assumed
that costs are attributed simply to payment from life
insurance policies at a low of $00 (uninsured) and a high
of $500,000 per HD. This is a conservative valuation;
many actuarial estimates would include loss of lifetime
hture income in HD settlements.

CONCLUSIONS
Wildlife rabies has increased dramatically in the past
decade. Economic impacts &om epizootic outbreaks of
specific variants of this disease are exerted upon diverse
agricultural, insurance, medical, and veterinary interests.
Due to greater incidences, PV and human PEP have been
cited traditionally as the major cost impacts of the
disease; however, of the 11 factors included in our model,
the maximum and largest ranges of per unit costs were

associated with LR, PEP, AR, and HD, with the potential
occurrence of high AR and HD costs rare events.
Empirical studies to determine pre-epizootic, epizootic,
and post-epizootic incidences for the factors are sorely
needed to allow improved economic projections of actual
costs of the disease. Determination of these incidences
and relative cost components will reduce the uncertainty
of economic impacts linked with wildlife rabies and will
allow improved policy decisions involving the
development and distribution of ORV for wildlife.
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